FDA Approves IMULDOSA® (ustekinumab-srlf), Accord BioPharma’s Biosimilar to STELARA® (ustekinumab), for the Treatment of Chronic Inflammatory Conditions
With the approval of IMULDOSA, Accord BioPharma’s (A division of Intas Pharmaceuticals) biosimilar portfolio continues to grow while expanding treatment…